Etoposide induced cytotoxicity mediated by ROS and ERK in human kidney proximal tubule cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep34064.pdf
Reference59 articles.
1. Bywater, M. J., Pearson, R. B., McArthur, G. A. & Hannan, R. D. Dysregulation of the basal RNA polymerase transcription apparatus in cancer. Nat Rev Cancer 13, 299–314, 10.1038/nrc3496 (2013).
2. Hande, K. R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34, 1514–1521 (1998).
3. Slevin, M. L. The clinical pharmacology of etoposide. Cancer 67, 319–329 (1991).
4. Beyer, J. et al. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Bone Marrow Transplant 20, 813–819, 10.1038/sj.bmt.1700980 (1997).
5. Kwon, H. K. et al. Etoposide Induces Necrosis Through p53-Mediated Antiapoptosis in Human Kidney Proximal Tubule Cells. Toxicol Sci 148, 204–219, 10.1093/toxsci/kfv182 (2015).
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells;Oxidative Medicine and Cellular Longevity;2024-03-11
2. The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays;npj Breast Cancer;2024-03-04
3. Temperature and CO2 interactively drive shifts in the compositional and functional structure of peatland protist communities;Global Change Biology;2024-03
4. Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma;Aging;2024-01-18
5. Oxidative stress induced by Etoposide anti-cancer chemotherapy drives the emergence of tumor-associated bacteria resistance to fluoroquinolones;Journal of Advanced Research;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3